Skip to main content

The Pemoline Model of Self-Injurious Behavior: An Update

  • Protocol
  • First Online:
Psychiatric Disorders

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2011))

  • 2949 Accesses

Abstract

Neurodevelopmental disorders typically comprise a complex constellation of behavioral symptoms and neurochemical abnormalities. However, many of the symptoms are inconsistently expressed within any one particular patient group or overlap between patient groups. In other words, there is usually heterogeneity of symptoms between diagnostic groups, and there is often partial homogeneity of symptoms across these groups. These include cognitive deficits, emotional lability, and perseverative or aberrant behaviors. Animal models of neurodevelopmental disorders typically reproduce or mimic specific genetic, neurochemical, and/or behavioral sequelae, although they typically fail to replicate the entire spectrum of biological and behavioral characteristics. Indeed, it may be impractical or even impossible to model the entire spectrum of characteristics of a disorder in any single animal model. A focus on one or more specific behavioral characteristics that occur in multiple neurodevelopmental disorders (e.g., self-injury) may be a fruitful strategy. The development of these behaviorally focused models may yield increased understanding of the endogenous and environmental factors that confer vulnerability for aberrant behaviors that commonly occur in these disorders. One such behaviorally focused animal model is the pemoline model of self-injurious behavior.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Matson JL, Minshawi NF, Gonzalez ML, Mayville SB (2006) The relationship of comorbid problem behaviors to social skills in persons with profound mental retardation. Behav Modif 30:496–506

    PubMed  Google Scholar 

  2. Matson JL, Nebel-Schwalm M (2007) Assessing challenging behaviors in children with autism spectrum disorders: a review. Res Dev Disabil 28:567–579

    PubMed  Google Scholar 

  3. Findling RL (2005) Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders. J Clin Psychiatry 66(Suppl 10):26–31

    CAS  PubMed  Google Scholar 

  4. Sarimski K (1997) Communication, social­emotional development and parenting stress in Cornelia-de-Lange syndrome. J Intellect Disabil Res 41(Pt1):70–75

    PubMed  Google Scholar 

  5. Bromley J, Emerson E (1995) Beliefs and emotional reactions of care staff working with people with challenging behaviour. J Intellect Disabil Res 39(Pt 4):341–352

    PubMed  Google Scholar 

  6. National Institutes of Health Consensus Statement (1989) Treatment of destructive behaviors in persons with developmental disabilities. J Autism Dev Disord 20:403–429

    Google Scholar 

  7. Kies SD, Devine DP (2004) Self­injurious behaviour: a comparison of caffeine and pemoline models in rats. Pharmacol Biochem Behav 79:587–598

    CAS  PubMed  Google Scholar 

  8. Blake BL, Muehlmann AM, Egami K, Breese GR, Devine DP, Jinnah HA (2007) Nifedipine suppresses self-injurious behaviors in animals. Dev Neurosci 29:241–250

    CAS  PubMed  Google Scholar 

  9. Muehlmann AM, Brown BD, Devine DP (2008) Pemoline-induced self-injurious behavior: a rodent model of pharmacotherapeutic efficacy. J Pharmacol Exp Ther 324:214–223

    CAS  PubMed  Google Scholar 

  10. Devine DP, Muehlmann AM (2009) Tiermodelle fur selbstverletzendes Verhalten (Animal models of self-injurious behavior). In: Schmahl C, Stiglmayr C (eds) Selbstverletzendes Verhaltenbei Stressassoziierten Erkrankungen (Self-injurious behaviour in stress-associated disorders). Verlag W. Kohlhammer, Stuttgart, Germany, pp 39–60

    Google Scholar 

  11. Muehlmann AM, Devine DP (2008) Glutamate-mediated neuroplasticity in an animal model of self-injurious behaviour. Behav Brain Res 189:32–40

    CAS  PubMed  Google Scholar 

  12. Yuan X, Devine DP (2016) The role of anxiety in vulnerability for self-injurious behaviour: studies in a rodent model. Behav Brain Res 311:201–209

    CAS  PubMed  Google Scholar 

  13. Symons FJ, Thompson T (1997) Self injurious behaviour and body site preference. J Intellect Disabil Res 41:456–468

    PubMed  Google Scholar 

  14. Kies SD, Turner CA, Lewis MH, Devine DP (2002) Effects of environmental complexity in an animal model of self-injury. Soc Neurosci Abstr 28:207.8

    Google Scholar 

  15. Beckett C, Bredenkamp D, Castle J, Groothues C, O’Connor TG, Rutter M (2002) Behavior patterns associated with institutional deprivation: a study of children adopted from Romania. J Dev Behav Pediatr 23:297–303

    PubMed  Google Scholar 

  16. Saito Y, Takashima S (2000) Neurotransmitter changes in the pathophysiology of Lesch-Nyhan syndrome. Brain Dev 22(Suppl 1):S122–S131

    PubMed  Google Scholar 

  17. Everett GM (1976) Comparative pharmacology of amphetamine and pemoline on biogenic amine systems. Fed Proc 35:405

    Google Scholar 

  18. Criswell HE, Johnson KB, Mueller RA, Breese GR (1993) Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D­aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats. J Pharmacol Exp Ther 265:1001–1010

    CAS  PubMed  Google Scholar 

  19. Tseng SH, Lin SM (1998) Substantia nigra lesion suppresses the antagonistic effects of N-methyl-D-aspartate receptor antagonist (MK-801) on the autotomy in the rat. Neurosci Lett 255:167–171

    CAS  PubMed  Google Scholar 

  20. King BH, Au D, Poland RE (1995) Pretreatment with MK-801 inhibits pemoline­induced self-biting behavior in prepubertal rats. Dev Neurosci 17:47–52

    CAS  PubMed  Google Scholar 

  21. Winchel RM, Stanley M (1991) Self-injurious behavior: a review of the behavior and biology of self-mutilation. Am J Psychiatry 148:306–317

    CAS  PubMed  Google Scholar 

  22. Accardo P (2003) Risperidone in children with autism and serious behavioral problems. J Pediatr 142:86–87

    PubMed  Google Scholar 

  23. Davis LL, Ryan W, Adinoff B, Petty F (2000) Comprehensive review of the psychiatric uses of valproate. J Clin Psychopharmacol 20:1S–17S

    CAS  PubMed  Google Scholar 

  24. Smathers SA, Wilson JG, Nigro MA (2003) Topiramate effectiveness in Prader-Willi syndrome. Pediatr Neurol 28:130–133

    PubMed  Google Scholar 

  25. Davanzo PA, King BH (1996) Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation. J Child Adolesc Psychopharmacol 6:273–279

    CAS  PubMed  Google Scholar 

  26. Sasso DA, Kalanithi PS, Trueblood KV, Pittenger C, Kelmendi B, Wayslink S, Malison RT, Krystal JH, Coric V (2006) Beneficial effects of the glutamate­modulating agent riluzole on disordered eating and pathological skin-picking behaviors. J Clin Psychopharmacol 26:685–687

    PubMed  Google Scholar 

  27. Pittenger C, Krystal JH, Coric V (2005) Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder. J Clin Psychiatry 66:1492–1493

    PubMed  Google Scholar 

  28. Rizvi ST (2002) Lamotrigine and borderline personality disorder. J Child Adolesc Psychopharmacol 12:365–366

    PubMed  Google Scholar 

  29. Genovese E, Napoli PA, Bolego ZN (1968) Group toxicity and autoaggressivity induced by 5-phenyl-2-imino-4-oxo-oxazolidine (pemoline). Boll Soc Ital Biol Sper 44:1953–1957

    CAS  PubMed  Google Scholar 

  30. Genovese E, Napoli PA, Bolego-Zonta N (1969) Self-aggressiveness: a new type of behavioural change induced by pemoline. Life Sci 8:513–515

    CAS  PubMed  Google Scholar 

  31. Kasim S, Jinnah HA (2002) Pharmacologic thresholds for self-injurious behavior in a genetic mouse model of Lesch-Nyhan disease. Pharmacol Biochem Behav 73:583–592

    CAS  PubMed  Google Scholar 

  32. King BH, Au D, Poland RE (1993) Low dose naltrexone inhibits pemoline-induced self-biting behavior in prepubertal rats. J Child Adol Psychopharmacol 3:71–79

    CAS  Google Scholar 

  33. King BH, Cromwell HC, Lee HT, Behrstock SP, Schmanke T, Maidment NT (1998) Dopaminergic and glutamatergic interactions in the expression of self-injurious behavior. Dev Neurosci 20:180–187

    CAS  PubMed  Google Scholar 

  34. Cromwell HC, Levine MS, King BH (1999) Cortical damage enhances pemoline-induced self-injurious behavior in prepubertal rats. Pharmacol Biochem Behav 62:223–227

    CAS  PubMed  Google Scholar 

  35. Cromwell HC, King BH, Levine MS (1997) Pemoline alters dopamine modulation of synaptic responses of neostriatal neurons in vitro. Dev Neurosci 19:497–504

    CAS  PubMed  Google Scholar 

  36. Turner CA, Panksepp J, Bekkedal M, Borkowski C, Burgdorf J (1999) Paradoxical effects of serotonin and opioids in pemoline-induced self-injurious behavior. Pharmacol Biochem Behav 63:361–366

    CAS  PubMed  Google Scholar 

  37. Muehlmann AM, Wilkinson JA, Devine DP (2011) Individual differences in vulnerability for self-injurious behavior: studies using an animal model. Behav Brain Res 217(1):148–154

    PubMed  Google Scholar 

  38. Muehlmann AM, Devine DP (2008) Self-injurious behavior: individual differences in neurotransmitter concentrations using an animal model. Keystone Symp: Towards Identifying the Pathophysiology of Autistic Syndromes C2:206

    Google Scholar 

  39. Kies SD, Devine DP (2002) Quantification of self-injurious behavior in an animal model of pemoline-induced self-injury. Int Meeting Autism Res 2:Pl.2.4

    Google Scholar 

  40. Razzak A, Fujiwara M, Ueki S (1975) Automutilation induced by clonidine in mice. Eur J Pharmacol 30:356–359

    CAS  PubMed  Google Scholar 

  41. Peters JM (1967) Caffeine-induced hemorrhagic automutilation. Arch Int Pharmacodyn Ther 169:139–146

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Darragh P. Devine .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Devine, D.P. (2019). The Pemoline Model of Self-Injurious Behavior: An Update. In: Kobeissy, F. (eds) Psychiatric Disorders. Methods in Molecular Biology, vol 2011. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9554-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9554-7_6

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-4939-9553-0

  • Online ISBN: 978-1-4939-9554-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics